Alberta Investment Management Corp - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alberta Investment Management Corp ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q4 2013$128,000
+82.9%
19,1400.0%0.00%
+100.0%
Q3 2013$70,000
+79.5%
19,1400.0%0.00%0.0%
Q2 2013$39,00019,1400.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Alistair Capital Management, L.L.C. 917,400$5,715,0002.56%
Fortress Investment Group LLC 2,481,596$15,460,0000.24%
PERKINS CAPITAL MANAGEMENT INC 14,000$87,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,332,260$8,386,0000.02%
TFS CAPITAL LLC 26,116$163,0000.01%
GROUP ONE TRADING, L.P. 54,815$342,0000.01%
Renaissance Technologies 218,913$1,364,0000.00%
Alberta Investment Management Corp 19,140$128,0000.00%
OAK RIDGE INVESTMENTS LLC 11,055$69,0000.00%
SUMMIT SECURITIES GROUP LLC 600$4,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders